Citation: Chao Liu, Liming Gong, Yanhong Liu, Shuangqing Wang, Hao Wu, Liqing Chen, Mingji Jin, Zhonggao Gao, Wei Huang. Lipoic acid-locked reduction-responsive core-cross-linked micelles delivering paclitaxel for triple-negative breast cancer treatment[J]. Chinese Chemical Letters, ;2025, 36(8): 110570. doi: 10.1016/j.cclet.2024.110570 shu

Lipoic acid-locked reduction-responsive core-cross-linked micelles delivering paclitaxel for triple-negative breast cancer treatment

Chao Liu ^{a, b, c, 1} ,
Liming Gong ^{a, c, 1} ,
Yanhong Liu ^{a, c} ,
Shuangqing Wang ^{a, c} ,
Hao Wu ^{a, c} ,
Liqing Chen ^{a, c} ,
Mingji Jin ^{a, c} ,
Zhonggao Gao ^{a, c, *,} ,
Wei Huang ^{a, c, *,}

a.
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Pharmaceutics, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
b.
State Key Laboratory of Advanced Medical Materials and Devices, Institute of Biomedical Engineering, Tianjin Institutes of Health Science, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China
c.
Beijing Key Laboratory of Drug Delivery Technology and Novel Formulations, Department of Pharmaceutics, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China

zggao@imm.ac.cn

huangwei@imm.ac.cn

Received Date: 12 June 2024
Revised Date: 16 October 2024
Accepted Date: 21 October 2024
Available Online: 22 October 2024

Figures(5)

Most anti-tumor agents suffer from systemic non-specific distribution and low aggregation in tumors, which not only decreases the therapeutic efficacy, but also causes systemic toxic side effects in the treatments of tumors. In recent years, the rapid development of nanotechnology has brought new ideas for the application of anti-tumor drugs. Nanomedicines, such as liposomes and micelles, can improve drug targeting and prolong systemic circulation time to promote anti-tumor efficacy and reduce toxic side effects. However, conventional micelles bear the risk of instability and premature drug leaking in the blood circulation. We designed a reduction-responsive core-cross-linked micelle PTX@Fmoc-LA-PEG efficiently encapsulating Paclitaxel (PTX) via π-π stacking and hydrophobic interactions of Fmoc and PTX. Moreover, the micelle was further locked based on the cross-linking properties of the disulfide bonds formed by lipoic acid (LA). As expected, the core-cross-linked micelles PTX@Fmoc-LA-PEG remained stable in normal physiological environments, while restoring the normal drug release rate of micelles under the highly reducing environment due to LA unlocking. The blank micelles (Fmoc-LA-PEG) exhibited excellent biocompatibility, while the drug-loaded micelles (PTX@Fmoc-LA-PEG) displayed a remarkable anti-tumor effect in vitro and in vivo experiments. These results suggested that core-cross-linked micelles PTX@Fmoc-LA-PEG have great potential to improve the targeting and stability of anti-tumor drugs.
- Core-cross-linked micelles,
- Reduction-responsive,
- Lipoic acid,
- Paclitaxel,
- Triple-negative breast cancer
1. [1]
  B. Ghosh, S. Biswas, J. Control. Release 332 (2021) 127–147.
2. [2]
  H. Deng, Y. Zhang, X. Wang, et al., Acta Biomater. 11 (2015) 126–136.
3. [3]
  H. Cabral, K. Miyata, K. Osada, et al., Chem. Rev. 118 (2018) 6844–6892. doi: 10.1021/acs.chemrev.8b00199
4. [4]
  H. Zhu, K. Ma, R. Ruan, et al., Chin. Chem. Lett. 35 (2024) 108536.
5. [5]
  Q. Sun, M. Radosz, Y. Shen, J. Control. Release 164 (2012) 156–169.
6. [6]
  H. Mutlu, E.B. Ceper, X. Li, et al., Macromol. Rapid Commun. 40 (2019) e1800650.
7. [7]
  A.L. Lee, S. Venkataraman, S.B. Sirat, et al., Biomaterials 33 (2012) 1921–1928.
8. [8]
  J.A. Xiong, F.H. Meng, C. Wang, et al., J. Mater. Chem. 21 (2011) 5786–5794. doi: 10.1039/c0jm04410e
9. [9]
  R. Yang, F. Meng, S. Ma, et al., Biomacromolecules 12 (2011) 3047–3055. doi: 10.1021/bm2006856
10. [10]
  C.J. Rijcken, C.J. Snel, R.M. Schiffelers, et al., Biomaterials 28 (2007) 5581–5593.
11. [11]
  Z. Zhang, L. Yin, C. Tu, et al., ACS Macro Lett. 2 (2013) 40–44.
12. [12]
  C. Deng, Y.J. Jiang, R. Cheng, et al., Nano Today 7 (2012) 467–480.
13. [13]
  Y. Li, W. Xiao, K. Xiao, et al., Angew. Chem. Int. Ed. 51 (2012) 2864–2869. doi: 10.1002/anie.201107144
14. [14]
  Y. Li, K. Xiao, J. Luo, et al., Biomaterials 32 (2011) 6633–6645.
15. [15]
  H. Sun, B. Guo, R. Cheng, et al., Biomaterials 30 (2009) 6358–6366.
16. [16]
  Y.C. Huang, Y.S. Yang, T.Y. Lai, et al., Polymer 53 (2012) 913–922. doi: 10.1115/SBC2012-80430
17. [17]
  Y.L. Li, L. Zhu, Z.Z. Liu, et al., Angew. Chem. Int. Ed. 48 (2009) 9914–9918. doi: 10.1002/anie.200904260
18. [18]
  R. Wei, L. Cheng, M. Zheng, et al., Biomacromolecules 13 (2012) 2429–2438. doi: 10.1021/bm3006819
19. [19]
  L. Wu, Y. Zou, C. Deng, et al., Biomaterials 34 (2013) 5262–5272.
20. [20]
  P. Zhang, Y.X. Huang, H. Liu, et al., Biomaterials 35 (2014) 7146–7156.
21. [21]
  M. Huo, J. Yuan, L. Tao, et al., Polym. Chem. 5 (2014) 1519–1528.
22. [22]
  R. Cheng, F. Feng, F.H. Meng, et al., J. Control. Release 152 (2011) 2–12.
23. [23]
  S.H. Lee, M.K. Gupta, J.B. Bang, et al., Adv. Healthc. Mater. 2 (2013) 908–915. doi: 10.1002/adhm.201200423
24. [24]
  J. Jiang, X. Cui, Y. Huang, et al., Nano Biomed. Eng. 16 (2024) 152–187. doi: 10.26599/nbe.2024.9290060
25. [25]
  A. Bast, G.R.M.M. Haenen, Biofactors 17 (2003) 207–213. doi: 10.1002/biof.5520170120
26. [26]
  J. Bustamante, J.K. Lodge, L. Marcocci, et al., Free Radic. Biol. Med. 24 (1998) 1023–1039.
27. [27]
  A.R. Smith, S.V. Shenvi, M. Widlansky, et al., Curr. Med. Chem. 11 (2004) 1135–1146. doi: 10.2174/0929867043365387
28. [28]
  A. Maczurek, K. Hager, M. Kenklies, et al., Adv. Drug Deliv. Rev. 60 (2008) 1463–1470.
29. [29]
  M.J. Stevens, I. Obrosova, X. Cao, et al., Diabetes 49 (2000) 1006–1015. doi: 10.2337/diabetes.49.6.1006
30. [30]
  K.P. Shay, R.F. Moreau, E.J. Smith, et al., Biochim. Biophys. Acta 1790 (2009) 1149–1160.
31. [31]
  X. Zhou, X. Dai, J. Tan, et al., ACS Appl. Mater. Interfaces 13 (2021) 56850–56857. doi: 10.1021/acsami.1c16293
32. [32]
  Y. Xu, F. Meng, R. Cheng, et al., Macromol. Biosci. 9 (2009) 1254–1261. doi: 10.1002/mabi.200900233
33. [33]
  Y.C. Chen, R. Xia, Y.X. Huang, et al., Nat. Commun. 7 (2016) 13443.
34. [34]
  P. Zhang, Y. Huang, H. Liu, et al., Biomaterials 35 (2014) 7146–7156.
35. [35]
  P. Zhang, Y. Huang, Y.T. Kwon, et al., Mol. Pharm. 12 (2015) 1680–1690. doi: 10.1021/acs.molpharmaceut.5b00157
36. [36]
  D. Huang, J. Gui, X. Chen, et al., ACS Appl. Mater. Interfaces 14 (2022) 51776–51789. doi: 10.1021/acsami.2c15881
37. [37]
  J. Xu, X. Zhang, Y. Chen, et al., Mol. Pharm. 14 (2016) 31–41.
38. [38]
  R. Ngoune, A. Peters, D. von Elverfeldt, et al., J. Control. Release 238 (2016) 58–70.
39. [39]
  Q. Liu, X. Chen, Y. Jiang, et al., Adv. Funct. Mater. 34 (2023) 2311677.
40. [40]
  B. Chen, L. Gong, J. Feng, et al., Chin. Chem. Lett. 35 (2024) 109432.
41. [41]
  X. Yu, T. Shang, G. Zheng, et al., Chin. Chem. Lett. 33 (2022) 1895–1900.
42. [42]
  M. Attia, E.A. Essa, R.M. Zaki, et al., Antioxidants 9 (2020) 359. doi: 10.3390/antiox9050359
43. [43]
  J. Tripathy, A. Tripathy, M. Thangaraju, et al., Life Sci. 207 (2018) 15–22.
44. [44]
  M.J. Jeon, W.G. Kim, S. Lim, et al., Mol. Cell Endocrinol. 419 (2016) 113–123.
1. [1]
  Lin Li , Bingjun Sun , Jin Sun , Lin Chen , Zhonggui He . Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109538-. doi: 10.1016/j.cclet.2024.109538
2. [2]
  Wenfeng Zang , Yixin Sun , Jingyi Zhang , Yanzhong Hao , Qianhui Jin , Hongying Xiao , Zuo Zhang , Xianbao Shi , Jin Sun , Zhonggui He , Cong Luo , Bingjun Sun . Two-tailed modification module tuned steric-hindrance effect enabling high therapeutic efficacy of paclitaxel prodrug nanoassemblies. Chinese Chemical Letters, 2025, 36(5): 110230-. doi: 10.1016/j.cclet.2024.110230
3. [3]
  Yi Cao , Xiaojiao Ge , Yuanyuan Wei , Lulu He , Aiguo Wu , Juan Li . Tumor microenvironment-activatable neuropeptide-drug conjugates enhanced tumor penetration and inhibition via multiple delivery pathways and calcium deposition. Chinese Chemical Letters, 2024, 35(4): 108672-. doi: 10.1016/j.cclet.2023.108672
4. [4]
  Yixin Sun , Keke Yu , Xiuchun Guo , Lanlan Zong , Zhonggui He , Xiaohui Pu . Three-in-one reduction and acid-ignited micelles amplify antitumor efficacy via precise synergistic delivery of paclitaxel and naringenin. Chinese Chemical Letters, 2025, 36(6): 110393-. doi: 10.1016/j.cclet.2024.110393
5. [5]
  Peng Gao , Yuanyuan Chen , Qianlin He , Xue Liu , Echuan Tan , Zhiqiang Yu , Hui Wang . Highly efficient adoptive cell therapy of metastatic triple negative breast cancer with bioactive covalent organic framework-engineered macrophages. Chinese Chemical Letters, 2025, 36(8): 110585-. doi: 10.1016/j.cclet.2024.110585
6. [6]
  Li Fu , Ziye Su , Shuyang Wu , Yanfen Cheng , Chuan Hu , Jinming Zhang . Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 2025, 36(5): 110227-. doi: 10.1016/j.cclet.2024.110227
7. [7]
  Di Wang , Qing-Song Chen , Yi-Ran Lin , Yun-Xin Hou , Wei Han , Juan Yang , Xin Li , Zhen-Hai Wen . Tuning strategies and electrolyzer design for Bi-based nanomaterials towards efficient CO2 reduction to formic acid. Chinese Journal of Structural Chemistry, 2024, 43(8): 100346-100346. doi: 10.1016/j.cjsc.2024.100346
8. [8]
  Haijing Cui , Weihao Zhu , Chuning Yue , Ming Yang , Wenzhi Ren , Aiguo Wu . Recent progress of ultrasound-responsive titanium dioxide sonosensitizers in cancer treatment. Chinese Chemical Letters, 2024, 35(10): 109727-. doi: 10.1016/j.cclet.2024.109727
9. [9]
  Ruifeng Liang , Yanbei Tu , Peng Hua , Yongzhuo Huang , Meiwan Chen . ROS-responsive micelles co-loaded dexamethasone and pristimerin to restore the homeostasis of the inflammatory microenvironment for rheumatoid arthritis therapy. Chinese Chemical Letters, 2025, 36(6): 110335-. doi: 10.1016/j.cclet.2024.110335
10. [10]
  Jiangqi Ning , Junhan Huang , Yuhang Liu , Yanlei Chen , Qing Niu , Qingqing Lin , Yajun He , Zheyuan Liu , Yan Yu , Liuyi Li . Alkyl-linked TiO2@COF heterostructure facilitating photocatalytic CO2 reduction by targeted electron transport. Chinese Journal of Structural Chemistry, 2024, 43(12): 100453-100453. doi: 10.1016/j.cjsc.2024.100453
11. [11]
  Mengjuan Sun , Muye Zhou , Yifang Xiao , Hailei Tang , Jinhua Chen , Ruitao Zhang , Chunjiayu Li , Qi Ya , Qian Chen , Jiasheng Tu , Qiyue Wang , Chunmeng Sun . Reversibly size-switchable polyion complex micelles for antiangiogenic cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109110-. doi: 10.1016/j.cclet.2023.109110
12. [12]
  Jingtai Bi , Yupeng Cheng , Mengmeng Sun , Xiaofu Guo , Shizhao Wang , Yingying Zhao . Efficient and selective photocatalytic nitrite reduction to N₂ through CO₂ anion radical by eco-friendly tartaric acid activation. Chinese Chemical Letters, 2024, 35(11): 109639-. doi: 10.1016/j.cclet.2024.109639
13. [13]
  Min Song , Qian Zhang , Tao Shen , Guanyu Luo , Deli Wang . Surface reconstruction enabled o-PdTe@Pd core-shell electrocatalyst for efficient oxygen reduction reaction. Chinese Chemical Letters, 2024, 35(8): 109083-. doi: 10.1016/j.cclet.2023.109083
14. [14]
  Jingtao Bi , Yupeng Cheng , Mengmeng Sun , Xiaofu Guo , Shizhao Wang , Yingying Zhao . Corrigendum to “Efficient and selective photocatalytic nitrite reduction to N₂ through CO₂ anion radical by eco-friendly tartaric acid activation” [Chinese Chemical Letters 35 (2024) 109639]. Chinese Chemical Letters, 2025, 36(7): 110867-. doi: 10.1016/j.cclet.2025.110867
15. [15]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
16. [16]
  Ling-Ling Wu , Xiangchuan Meng , Qingyang Zhang , Xiaowan Han , Feiya Yang , Qinghua Wang , Hai-Yu Hu , Nianzeng Xing . Heavy-atom engineered hypoxia-responsive probes for precisive photoacoustic imaging and cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108663-. doi: 10.1016/j.cclet.2023.108663
17. [17]
  Shuang Liang , Jianjun Yao , Dan Liu , Mengli Zhou , Yong Cui , Zhaohui Wang . Tumor-responsive covalent organic polymeric nanoparticles enhancing STING activation for cancer immunotherapy. Chinese Chemical Letters, 2025, 36(3): 109856-. doi: 10.1016/j.cclet.2024.109856
18. [18]
  Keqiang Shi , Xiujuan Hong , Dongyan Xu , Tao Pan , Huiwen Wang , Hongru Feng , Cheng Guo , Yuanjiang Pan . Analysis of RNA modifications in peripheral white blood cells from breast cancer patients by mass spectrometry. Chinese Chemical Letters, 2025, 36(3): 110079-. doi: 10.1016/j.cclet.2024.110079
19. [19]
  Xinyue Han , Yunhan Yang , Jiayin Lu , Yuxiang Lin , Dongxue Zhang , Ling Lin , Liang Qiao . Efficient serum lipids profiling by TiO₂-dopamin-assisted MALDI-TOF MS for breast cancer detection. Chinese Chemical Letters, 2025, 36(5): 110183-. doi: 10.1016/j.cclet.2024.110183
20. [20]
  Qianyun Ye , Yuanyuan Liang , Yuhe Yuan , Xiaohuan Sun , Liqi Zhu , Xuan Wu , Jie Han , Rong Guo . pH-responsive chiral supramolecular cysteine-Zn²⁺-indocyanine green assemblies for triple-level chirality-specific anti-tumor efficacy. Chinese Chemical Letters, 2025, 36(5): 110432-. doi: 10.1016/j.cclet.2024.110432

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(26)
HTML views(2)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142